Overall, the NUF2-HMGA2 axis was identified as a novel interaction regulating tumorigenesis and progression in ccRCC, and thus can be an ideal therapeutic target and a promising prognostic indicator for ccRCC. The gene discussed is HMGA2; the disease is nonpapillary renal cell carcinoma.